Seeking Alpha

More on McKesson (MCK +3.5%) Q3: net profit +35% to $401M, boosted by a strong performance at...

More on McKesson (MCK +3.5%) Q3: net profit +35% to $401M, boosted by a strong performance at its U.S. pharmaceutical distribution business. The company also benefits from the introduction of generic drugs as patents expires across the industry. Raises low end of FY adjusted EPS by 10 cents to $7.15-$7.35 vs consensus of $7.26. (PSS acquisition)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs